Friday February 19, 2021
ECONOMYNEXT – Sri Lanka will purchase 10 million doses of the Oxford-AstraZeneca-Covishield vaccine from the Serum Institute of India, the Hindustan Times reported today (19).
The SPC said in a statement today that a purchase agreement has been signed with the Serum Institute in this regard, with the payment expected to be made today.
Attorney General Dappula de Livera approved the purchase agreement earlier this week. (Colombo/Feb19/2021)